subscribeSubscribe
The French speciality pharmaceutical, Juvisé acquires two onco products from AZ

The French speciality pharmaceutical, Juvisé acquires two onco products from AZ
PRESS RELEASE
20 Dec 2020
Share Share
AstraZeneca sells Amrimidx and Casodex European rights to Juvise

AstraZeneca sells Amrimidx and Casodex European rights to Juvise
PHARMAFILE
21 Dec 2019
Share Share
Pfizer, Astellas` Xtandi racks up more data for new prostate cancer approval

Pfizer, Astellas` Xtandi racks up more data for new prostate cancer approval
Carly Helfand FIERCE PHARMA
03 Jun 2019
Share Share
Anvisa Suspends Batch of Casodex (bicalutamide) 50mg

Anvisa Suspends Batch of Casodex (bicalutamide) 50mg
ANVISA
24 Feb 2018
Share Share
ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million

ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
PR NEWSWIRE
30 Dec 2017
Share Share
AZ books 3 percent sales drop for Q3

AZ books 3 percent sales drop for Q3
Zachary Brennan PHARMA TIMES
09 Nov 2017
Share Share
US FDA Approves Xtandi Capsules for Advanced Prostate Cancer

US FDA Approves Xtandi Capsules for Advanced Prostate Cancer
PHARMABIZ
25 Oct 2016
Share Share
FDA Approves Supplemental New Drug Application for XTANDI Capsules

FDA Approves Supplemental New Drug Application for XTANDI Capsules
PRNEWSWIRE
21 Oct 2016
Share Share
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection

Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
EDQM
19 Sep 2016
Share Share
Journal of Clinical Oncology Publishes the STRIVE trial of enzalutamide

Journal of Clinical Oncology Publishes the STRIVE trial of enzalutamide
PRNEWSWIRE
26 Jan 2016
Share Share